USCA RIA’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,525
Closed -$522K 558
2020
Q4
$522K Buy
4,525
+2,000
+79% +$224K 0.04% 320
2020
Q3
$246K Sell
2,525
-37
-1% -$4.26K 0.02% 393
2020
Q2
$314K Sell
2,562
-100
-4% -$11.3K 0.03% 348
2020
Q1
$233K Hold
2,662
0.03% 353
2019
Q4
$278K Buy
2,662
+550
+26% +$61.7K 0.02% 400
2019
Q3
$243K Buy
2,112
+312
+17% +$47.4K 0.02% 399
2019
Q2
$310K Hold
1,800
0.03% 360
2019
Q1
$303K Buy
+1,800
New +$268K 0.03% 347
2014
Q4
Sell
-3,500
Closed -$283K 359
2014
Q3
$283K Buy
3,500
+1,000
+40% +$88.5K 0.09% 244
2014
Q2
$268K Buy
+2,500
New +$174K 0.09% 234

Other funds holding GWPH

USCA RIA's GWPH Position: Q1 2021 in Review

USCA RIA sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 4,525 shares — an estimated $522K sold.

USCA RIA first reported a position in GWPH in Q2 2014 and held it in 10 quarters. The position peaked at $522K in Q4 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • USCA RIA reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • USCA RIA sold 4,525 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $522K.
  • USCA RIA first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 10 quarters.
  • USCA RIA's GW Pharmaceuticals Plc American Depositary Shares position peaked at $522K in Q4 2020.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on USCA RIA's 13F filing for Q1 2021, filed 27 Apr 2021.